Girard Partners Ltd. Charles River Laboratories International, Inc. Transaction History
Girard Partners Ltd.
- $1.06 Billion
- Q2 2024
A detailed history of Girard Partners Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Girard Partners Ltd. holds 27,594 shares of CRL stock, worth $4.27 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
27,594
Previous 27,497
0.35%
Holding current value
$4.27 Million
Previous $7.45 Million
23.49%
% of portfolio
0.54%
Previous 0.7%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
51.4MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$954 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$788 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$631 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$330 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$300 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...